Nectar Lifesciences Limited
NSE: NECLIFE BSE: NECLIFE
NSE
18.97
-0.51 (-2.62%)
Prev Close
19.48
Open Price
19.01
Volume
225,083
Today Low / High
18.71 / 19.45
52 WK Low / High
13.05 / 41
Range
18 - 20
BSE
19.01
-0.40 (-2.06%)
Prev Close
19.41
Open Price
19.06
Volume
25,200
Today Low / High
18.9 / 19.53
52 WK Low / High
13.25 / 40.9
Range
18 - 20
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 18.97 (target range: 18 - 20), reflecting a change of -0.51 (-2.61807%). On the BSE, it is listed at 19.01 (target range: 18 - 20), showing a change of -0.4 (-2.06079%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
07 Jan
19.01
-0.21%
06 Jan
18.99
2.58%
05 Jan
19.70
-2.94%
02 Jan
20.80
-3.27%
01 Jan
19.62
3.87%
31 Dec
18.45
5.20%
30 Dec
19.00
-2.68%
29 Dec
19.09
0.00%
26 Dec
20.09
0.00%
24 Dec
21.14
0.00%
23 Dec
22.20
0.23%
22 Dec
22.20
-0.18%
19 Dec
21.29
2.44%
18 Dec
21.10
0.19%
17 Dec
21.29
-0.99%
16 Dec
21.14
0.24%
15 Dec
21.04
-0.19%
12 Dec
21.00
0.19%
11 Dec
21.12
-0.85%
10 Dec
21.10
-0.28%
Nectar Lifesciences Limited Graph
Nectar Lifesciences Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Nectar Lifesciences Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 18.97, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 19.01 | 19.20 | 17.28 - 21.12 |
| 19.39 | 15.51 - 23.27 | ||
| 19.58 | 13.71 - 25.45 | ||
| Bearish Scenario | 19.01 | 18.82 | 16.94 - 20.70 |
| 18.63 | 14.90 - 22.36 | ||
| 18.44 | 12.91 - 23.97 |
Overview of Nectar Lifesciences Limited
ISIN
INE023H01027
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
2,464,852
Market Cap
4,254,230,601
Last Dividend
0
Official Website
IPO Date
2005-07-18
DCF Diff
-37.17
DCF
56
Financial Ratios Every Investor Needs
Stock Dividend of NECLIFE
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2020-09-11 | September 11, 20 | 4.3195 | 4.3195 | 2020-09-14 | 2020-10-21 | |
| 2019-09-19 | September 19, 19 | 4.3195 | 4.3195 | 2019-09-21 | 2019-10-27 | 2019-05-25 |
| 2018-09-19 | September 19, 18 | 4.3195 | 4.3195 | 2018-09-21 | 2018-10-27 | 2018-05-28 |
| 2017-09-20 | September 20, 17 | 4.3195 | 4.3195 | 2017-09-21 | 2017-10-28 | 2017-06-27 |
| 2016-09-22 | September 22, 16 | 8.639 | 8.639 | 2016-09-23 | 2016-10-30 | 2016-05-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,669.97 Cr | 1,368.01 Cr | 301.96 Cr | 0.1808 | 16.22 Cr | 17.80 Cr | -88.85 Cr | -113.68 Cr | -5.07 | -24.57 Cr | -0.0681 |
| 2024-03-31 | 1,684.09 Cr | 1,202.24 Cr | 481.84 Cr | 0.2861 | 6.71 Cr | 17.19 Cr | 389.06 Cr | 5.00 Cr | 0.22 | 168.61 Cr | 0.0030 |
| 2023-03-31 | 1,523.67 Cr | 1,465.68 Cr | 57.99 Cr | 0.0381 | 2.65 Cr | 14.28 Cr | -4.10 Cr | -24.18 Cr | -1.08 | 99.50 Cr | -0.0159 |
| 2022-03-31 | 1,668.83 Cr | 1,369.51 Cr | 299.33 Cr | 0.1794 | 3.07 Cr | 15.02 Cr | 101.60 Cr | 25.05 Cr | 1.12 | 160.99 Cr | 0.0150 |
| 2021-03-31 | 1,543.30 Cr | 1,285.73 Cr | 257.57 Cr | 0.1669 | 2.44 Cr | 17.41 Cr | 62.01 Cr | -73.26 Cr | -3.27 | 61.25 Cr | -0.0475 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 19.22 Cr | 2,047.23 Cr | 1,091.12 Cr | 956.1068 Cr | 582.02 Cr | 562.80 Cr | 690.16 Cr | 633.33 Cr | 0.00 Cr | 0.72 Cr | 0.24 Cr | 1,021.5414 Cr |
| 2024-03-31 | 19.81 Cr | 2,191.06 Cr | 1,121.81 Cr | 1,069.2470 Cr | 635.54 Cr | 615.73 Cr | 776.53 Cr | 656.06 Cr | 0.00 Cr | 0.75 Cr | -0.26 Cr | 972.8170 Cr |
| 2023-03-31 | 17.58 Cr | 2,189.21 Cr | 1,124.62 Cr | 1,064.5946 Cr | 753.83 Cr | 736.25 Cr | 672.60 Cr | 690.43 Cr | 0.00 Cr | 0.77 Cr | 0.24 Cr | 890.9270 Cr |
| 2022-03-31 | 17.78 Cr | 2,390.83 Cr | 1,302.93 Cr | 1,087.9040 Cr | 859.93 Cr | 842.15 Cr | 721.26 Cr | 765.17 Cr | 0.00 Cr | 0.80 Cr | 0.24 Cr | 1,003.8330 Cr |
| 2021-03-31 | 25.50 Cr | 2,388.11 Cr | 1,326.09 Cr | 1,062.0290 Cr | 903.41 Cr | 877.91 Cr | 655.32 Cr | 832.15 Cr | 6.71 Cr | 0.82 Cr | 13.02 Cr | 1,187.3920 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 169.4380 Cr | -41.9304 Cr | -128.0920 Cr | 125.6432 Cr | -0.5844 Cr | 19.2216 Cr | -43.7948 Cr | -161.5340 Cr | -53.5137 Cr | 0.0000 Cr | 0.0000 Cr |
| 2024-03-31 | 224.6860 Cr | -17.0250 Cr | -205.4350 Cr | 195.2710 Cr | 2.2260 Cr | 19.8060 Cr | -29.4150 Cr | 4.9950 Cr | -118.2930 Cr | 0.0000 Cr | 0.0000 Cr |
| 2023-03-31 | 133.6510 Cr | 51.7040 Cr | -185.5830 Cr | 103.5910 Cr | -0.2280 Cr | 17.5800 Cr | -30.0600 Cr | -42.4199 Cr | -109.0960 Cr | 0.0000 Cr | 0.0000 Cr |
| 2022-03-31 | 95.0050 Cr | 16.6440 Cr | -119.3800 Cr | 70.0350 Cr | -7.7310 Cr | 17.8080 Cr | -24.9700 Cr | 34.0800 Cr | -50.5690 Cr | 0.0000 Cr | 0.0000 Cr |
| 2021-03-31 | 21.3790 Cr | -28.6240 Cr | 11.4900 Cr | -9.8620 Cr | 4.2450 Cr | 25.5390 Cr | -31.2410 Cr | -59.4530 Cr | 124.6460 Cr | -1.1210 Cr | 0.0000 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 5.71 Cr | 4.31 Cr | 1.40 Cr | 0.2453 | -0.53 Cr | -176.01 Cr | -7.85 | -0.30 Cr | -30.8182 |
| 2025-06-30 | 280.67 Cr | 263.54 Cr | 17.13 Cr | 0.0610 | -78.41 Cr | -63.23 Cr | -2.82 | -61.54 Cr | -0.2253 |
| 2025-03-31 | 428.91 Cr | 502.58 Cr | -73.68 Cr | -0.1718 | -170.07 Cr | -130.09 Cr | -5.80 | -154.23 Cr | -0.3033 |
| 2024-12-31 | 454.33 Cr | 332.04 Cr | 122.29 Cr | 0.2692 | 29.10 Cr | 7.84 Cr | 0.35 | 45.28 Cr | 0.0173 |
| 2024-09-30 | 427.88 Cr | 296.04 Cr | 131.84 Cr | 0.3081 | 27.78 Cr | 5.60 Cr | 0.25 | 44.02 Cr | 0.0131 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 5.93 Cr | 0.53 Cr | 13.97 Cr | 55.17 Cr | 2.98 Cr | 258.99 Cr | 27.59 Cr | 1,814.76 Cr | 1,097.89 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 19.75 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -956.11 Cr |
| 2025-03-31 | 19.22 Cr | 0.53 Cr | 27.26 Cr | 346.34 Cr | 690.16 Cr | 1,237.59 Cr | 633.33 Cr | 2,047.23 Cr | 1,091.12 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 18.73 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,077.82 Cr |
| 2024-09-30 | 18.24 Cr | 0.49 Cr | 18.73 Cr | 380.13 Cr | 749.38 Cr | 1,305.43 Cr | 633.29 Cr | 2,183.23 Cr | 1,105.42 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | -63.23 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | -130.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 7.84 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 5.60 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 2.97 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2008-11-12 | November 12, 08 | 10:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,782.60 | ₹4,277,054,517,522.00 | ₹3,059,410.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,642.50 | ₹1,763,375,042,650.00 | ₹423,878.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,092.20 | ₹1,384,986,429,568.00 | ₹893,670.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,242.80 | ₹1,034,646,566,070.00 | ₹1,215,293.00 |
| Lupin Limited | LUPIN | ₹2,214.30 | ₹1,011,489,596,126.00 | ₹1,368,002.00 |
| Mankind Pharma Limited | MANKIND | ₹2,311.80 | ₹954,322,765,450.00 | ₹980,745.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹927.55 | ₹933,332,337,425.00 | ₹517,994.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,235.40 | ₹717,522,325,054.00 | ₹2,361,325.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,806.50 | ₹694,254,172,500.00 | ₹188,590.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,128.50 | ₹609,228,152,787.00 | ₹1,358,026.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,113.10 | ₹596,318,529,498.00 | ₹1,278,289.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,514.20 | ₹384,158,926,896.00 | ₹425,453.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,854.00 | ₹356,566,270,896.00 | ₹199,823.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,933.00 | ₹302,806,297,948.00 | ₹554,620.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,527.20 | ₹289,515,183,088.00 | ₹319,387.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,512.00 | ₹245,688,159,528.00 | ₹1,537,103.00 |
| Eris Lifesciences Limited | ERIS | ₹1,553.90 | ₹211,667,426,925.00 | ₹78,527.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,464.50 | ₹211,612,500,000.00 | ₹8,636.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹15,135.00 | ₹194,180,370,015.00 | ₹60,557.00 |
| Cohance Lifesciences Limited | COHANCE | ₹503.25 | ₹192,526,913,205.00 | ₹721,549.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,078.00 | ₹170,861,312,930.00 | ₹99,085.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹946.10 | ₹169,455,848,007.00 | ₹1,816,804.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹823.70 | ₹161,909,045,239.00 | ₹73,531.00 |
| Granules India Limited | GRANULES | ₹610.95 | ₹148,258,452,040.00 | ₹2,125,550.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,856.60 | ₹141,123,314,794.00 | ₹54,316.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹920.25 | ₹112,897,510,497.00 | ₹68,824.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,706.00 | ₹94,716,073,692.00 | ₹10,644.00 |
| Strides Pharma Science Limited | STAR | ₹977.20 | ₹90,071,176,121.00 | ₹196,306.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹454.75 | ₹69,623,160,876.00 | ₹103,194.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹747.25 | ₹67,736,190,442.00 | ₹99,424.00 |
| FDC Limited | FDC | ₹409.90 | ₹66,735,853,432.00 | ₹42,671.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹318.15 | ₹62,224,354,760.00 | ₹116,172.00 |
| Sequent Scientific Limited | SEQUENT | ₹209.08 | ₹52,233,164,077.00 | ₹333,928.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹424.30 | ₹46,233,961,940.00 | ₹134,291.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹137.89 | ₹44,748,281,769.00 | ₹1,510,444.00 |
| Innova Captab Limited | INNOVACAP | ₹731.80 | ₹41,877,203,042.00 | ₹7,458.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹783.15 | ₹39,720,667,081.00 | ₹21,525.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,332.80 | ₹38,582,214,192.00 | ₹3,448.00 |
| Suven Life Sciences Limited | SUVEN | ₹173.42 | ₹38,222,811,121.00 | ₹552,898.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹404.00 | ₹36,873,080,000.00 | ₹52,604.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹332.10 | ₹33,303,820,243.00 | ₹22,119.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹435.40 | ₹30,654,663,550.00 | ₹18,210.00 |
Key Executives
Director of R&D and Additional Whole Time Director
Surulichamy Senthilkumar
Gender: Not Specified
Year Born: 1973
Chief Executive Officer
Amit Chadah
Gender: male
Year Born: 1970
President
Singh
Gender: male
Year Born:
Company Secretary & Compliance Officer
Sanjaymohan Singh Rawat
Gender: male
Year Born:
Chairman & MD
Sanjiv Goyal
Gender: male
Year Born: 1960
CFO, Wholetime Director of Finance & Additional Director
Sushil Kapoor
Gender: male
Year Born: 1958
FAQs about Nectar Lifesciences Limited
Who is the CEO of the company?
The CEO is Sanjiv Goyal.
What is the current market price of the stock?
The current price is ₹18.97.
What is the 52-week price range?
The range is ₹13.05-41.
What is the market capitalization of the company?
The market capitalization is ₹425.42 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -1.18.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Nectar Lifesciences Limited (ISIN: INE023H01027) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹425.42 crores and an average daily volume of 2,464,852 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.